Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome

British Journal of Surgery

Volumn 100, Issue 13, 2013, Pages 1719-1731

  Barrow, P ^a   Khan, M ^a   Lalloo, F ^b,c   Evans, D G ^b,c   Hill, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLON POLYPOSIS; COLORECTAL TUMOR; EARLY DIAGNOSIS; HEALTH; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INCIDENCE; MORTALITY; REGISTER; REVIEW;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DETECTION OF CANCER; HUMANS; INCIDENCE; REGISTRIES; WORLD HEALTH;

EID: 84887844616     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9316     Document Type: Review

References (57)

1. Bülow S, Faurschou Nielsen T, Bulow C, Bisgaard ML, Moesgaard F,. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis 1996; 11: 88-91.
2. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteus ME, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006; 354: 2751-2763.
3. Vasen HFA, Moslein G, Alonso A, Aretz S, Bernstein I, Bertario L, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57: 704-713.
4. Vasen HFA, Möslein G, Alonso A, Bernstein I, Bertario L, Bianco I, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 2007; 44: 353-362.
5. Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, et al. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 2008; 74: 233-242.
6. Bulow S, Burn J, Neale K, Northover J, Vasen H,. The establishment of a polyposis register. Int J Colorectal Dis 1993; 8: 34-38.
7. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJW, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-690.
8. Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013; 62: 812-823.
9. Bussey HJR,. Familial polyposis coli. Family studies, histopathology, differential diagnosis and results of treatment. In Relationship to Carcinoma. John Hopkins University Press: Baltimore, 1975; 47-58.
10. Myrhøj T, Bernstein I, Bisgaard ML, Svendsen LB, Sondergaard JO, Mohr J, et al. The establishment of an HNPCC register. Anticancer Res 1994; 14: 1647-1650.
11. Church J, Kiringoda R, LaGuardia L,. Inherited colorectal cancer registries in the United States. Dis Colon Rectum 2004; 47: 674-648.
12. Bülow S., Results of national registration of familial adenomatous polyposis. Gut 2003; 52: 742-746.
13. Dunlop MG,; British Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002: 51 (Suppl V): v21-v27.
14. Mallinson EK, Newton KF, Bowen J, Lalloo F, Clancy T, Hill J, et al. The impact of screening and genetic registration on mortality and colorectal cancer incidence in familial adenomatous polyposis. Gut 2010; 59: 1378-1382.
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
16. Reeves BC, Deeks JJ, Higgins JPT, Wells GA,. Including non-randomized studies. In Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1, Higgins JPT, Green S, (eds) [updated September 2008 ]. The Cochrane Collaboration, 2008; 13.1-13.34.
17. Downs SH, Black N,. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998; 52: 377-384.
18. Naylor K, Ward J, Polite BN,. Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med 2012; 27: 1033-1046.
19. Alm T., Surgical treatment of hereditary adenomatosis of the colon and rectum in Sweden during the last 20 years. Part II. Patients with prophylactic operations, primary and late results. Discussion and summary. Acta Chir Scand 1975; 141: 228-237.
20. Utsonomiya J, Iwama T,. Studies of hereditary gastrointestinal polyposes. Asian Med J 1978; 21: 12-32.
21. Järvinen HJ, Husa A, Aukee S, Laitinen S, Matikainen M, Havia T,. Finnish Registry for familial adenomatous coli. Scand J Gastroenterol 1984; 19: 941-946.
22. Gebert HF, Jagelman DG, McGannon E,. Familial polyposis coli. Am Fam Physician 1986; 33: 127-137.
23. Bülow S., Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum 1986; 29: 102-107.
24. Berk T, Cohen Z, Mcleod RS, Cullen JB,. Surveillance in relatives of patients with adenomatous polyposis. Semin Surg Oncol 1987; 3: 105-108.
25. Macrae FA, St John DJB, Muir EP, Campbell J, Penfold B, Cuthbertson AM,. Impact of a hospital-based register on the management of familial adenomatous polyposis. Med J Aust 1989; 151: 552-557.
26. Vasen HF, Griffioen G, Offerhaus JA, Den Hartog Jager FC, Van Leeuwen-Cornelisse IS, Meera Khan P, et al. The value of screening and central registration of families with familial adenomatous polyposis. Dis Col Rectum 1990; 3: 227-230.
27. Rhodes M, Chapman PD, Burn J, Gunn A,. Role of a regional register for familial adenomatous polyposis: experience in the Northern Region. Br J Surg 1991; 78: 451-452.
28. Campbell WJ, Irwin ST, Parks TG,. The surgical management of familial adenomatous polyposis in Northern Ireland. Ulster Med J 1991; 60: 193-198.
29. Järvinen HJ,. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992; 33: 357-360.
30. Penna CP, Tiret E, Kartheuser AH, Alschwang S, Parc R,. [ Value of screening of familial adenomatous polyposis for the prevention of colorectal cancer.] Gastroenterol Clin Biol 1992; 16: 210-214.
31. Goh HS, Wong J,. The Singapore Polyposis Registry. Ann Acad Med 1992; 21: 290-293.
32. Morton DG, Macdonald F, Haydon J, Cullen R, Barker G, Hultén M, et al. Screening practice for familial adenomatous polyposis: the potential for regional registers. Br J Surg 1993; 80: 255-258.
33. Berk T, Stern HS,. Screening, management, and surveillance for families with familial adenomatous polyposis. Gastrointest Endosc Clin N Am 1993; 3: 725-736.
34. Bertario L, Presciuttini S, Sala P, Rossetti C, Pietroiusti M,. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Semin Surg Oncol 1994; 10: 225-235.
35. Bülow S, Bülow C, Faurschou Nielsen T, Karlsen L, Moesgaard F,. Centralised registration, prophylactic examination and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995; 30: 989-993.
36. Goldberg PA, Madden MV, du Toit E, Bailey S, Torrington M, Taynham WH,. The outcome of familial adenomatous polyposis in the absence of a polyposis registry. S Afr Med J 1995; 85: 272-276.
37. De Pietri S, Sassatelli R, Roncucci L, Bertoni G, Landi P, Sabadini G, et al. Clinical and biologic features of adenomatous coli in Northern Italy. Scand J Gastroenterol 1995; 30: 771-779.
38. Björk J, Akerbrant H, Iselius L, Alm T, Hultcrantz R,. Epidemiology of familial adenomatous polyposis in Sweden: changes over time and difference in phenotype between males and females. Scand J Gastroenterol 1999; 34: 1230-1235.
39. Galle T, Juel K, Bülow S,. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999; 34: 808-812.
40. Heiskanen I, Luostarinen T, Järvinen HJ,. Impact of screening examination on survival in familial adenomatous polyposis. Scand J Gastroenterol 2000; 35: 1284-1287.
41. Ho JW, Chu KM, Tse CW, Yuen ST,. Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong Med J 2002; 8: 342-347.
42. Reyes Moreno J, Ginard Vicens D, Vanrell M, Marino Z, Garau I, Llompart A, et al. [ Impact of a registry on survival in familial adenomatous polyposis.] Med Clin (Barc) 2007; 129: 51-52.
43. Garzõn-Benavides M, Pizarro-Moreno A, García-Lozano R, Herrero-Garrido MI, Hervás-Molina AJ, Márquez-Galán JL, et al. Andalusian Registry for Familial Adenomatous Polyposis. Analysis of patients included. Rev Esp Enferm Dig (Madrid) 2010; 102: 653-657.
44. Dalpatadu KU, Anwar N, Wijesuriya SRE, Kumarage SK, Amarasinghe B, Deen KI,. Uses of a familial adenomatous polyposis registry. Ceylon Med J 2011; 56: 66-69.
45. Gibbons DC, Sinha A, Phillips RKS, Clark SK,. Colorectal cancer: no longer the issue in familial adenomatous polyposis? Fam Cancer 2011; 10: 11-20.
46. Iwama T, Tamura K, Morito T, Hirai T, Hasegawa H, Koichi K, et al.; Japanese Society for Cancer of the Colon and Rectum. A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004; 9: 308-316.
47. Vasen HF, Nagengast FM, Griffioen G, Menko F, Kleineuker JH, Offerhaus GJ, et al. Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families. Eur J Cancer 1995; 31A: 1145-1148.
48. Järvinen HJ, Mecklin J-P, Sistonen P,. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-1411.
49. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834.
50. Renkonen-Sinisalo L, Aarnio M, Mecklin J-P, Järvinen H,. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 2000; 24: 137-142.
51. Arrigoni A, Sprujevnik T, Alvisi V, Rossi A, Ricci G, Pennazio M, et al. Clinical identification and long-term surveillance of 22 hereditary non-polyposis colon cancer Italian families. Eur J Gastroenterol Hepatol 2005; 17: 213-219.
52. Dove Edwin I, Sasieni P, Adams J, Thomas HJ,. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005; 331: 1047.
53. Stupart DA, Goldberg PA, Algar U, Ramesar R,. Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation. Colorectal Dis 2009; 11: 126-130.
54. Stupart DA, Goldberg PA, Algar U, Ramesar R,. Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation. Fam Cancer 2009; 8: 519-523.
55. Stuckless S, Green JS, Morgenstern M, Kennedy C, Green RC, Woods MO, et al. Impact of colonoscopic screening in male and female Lynch syndrome mutation carriers with an MSH2 mutation. Clin Genet 2012; 82: 439-445.
56. de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006; 130: 665-671.
57. Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, et al.; Colon Cancer Family Registry. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 2331-2343.